SUBCUTANEOUS DRUG ABSORPTION IMPAIRED

This adverse event was reported 561 times

These drugs are most commonly taken by patients reporting SUBCUTANEOUS DRUG ABSORPTION IMPAIRED:

# Drug Count
0 DICLOFENAC SODIUM 268
1 RITUXIMAB 266
2 ACETAMINOPHEN 263
3 DICLOFENAC 261
4 ADALIMUMAB 254
5 METHOTREXATE SODIUM 244
6 NAPROXEN SODIUM 243
7 ADALIMUMAB-ADAZ 237
8 SULFASALAZINE 231
9 PANTOPRAZOLE 228
See all common drugs associated with SUBCUTANEOUS DRUG ABSORPTION IMPAIRED

SUBCUTANEOUS DRUG ABSORPTION IMPAIRED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 37 0.0538
1 Interleukin-17A Antagonist [EPC] 252 0.0068
2 Provitamin D2 Compound [EPC] 201 0.0068
3 Endoglycosidase [EPC] 8 0.0043
4 Substance P/Neurokinin-1 Receptor Antagonist [EPC] 29 0.0033
5 Aminosalicylate [EPC] 247 0.0025
6 Human C1 Esterase Inhibitor [EPC] 9 0.0023
7 Antirheumatic Agent [EPC] 223 0.0021
8 Interleukin-23 Antagonist [EPC] 219 0.0021
9 Interleukin-12 Antagonist [EPC] 216 0.0021
See all drug classes enriched for association with SUBCUTANEOUS DRUG ABSORPTION IMPAIRED